Company intelligence / Profile preview

G9 Ventures

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

G9 Ventures is a private early-stage investment firm, not a drug-development biotech or pharmaceutical company. The firm invests in consumer and technology brands that help people live, look, and feel better, with exposure to categories including health, wellness, digital health, beauty, and consumer products. Its portfolio includes healthcare- and wellness-related companies such as Ro, Midi Health, Function Health, Evvy, Little Otter, and Hey Jane, but G9 Ventures itself does not appear to operate a therapeutic pipeline. For biotech analysts, the most relevant framing is that G9 Ventures is a sector-adjacent investor with selective healthcare and health-tech exposure rather than an operating life sciences company.

Industry: Investors

Beyond the preview

Go deeper on G9 Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on G9 Ventures.

Explore the full profile